SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-15-005981
Filing Date
2015-11-04
Accepted
2015-11-04 16:04:51
Documents
18
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gff10q_110415p.htm 10-Q 630032
2 EXHIBIT 10.1 exh_101.htm EX-10.1 43753
3 EXHIBIT 10.2 exh_102.htm EX-10.2 156723
4 EXHIBIT 10.3 exh_103.htm EX-10.3 108797
5 EXHIBIT 31.1 exh_311.htm EX-31.1 8902
6 EXHIBIT 31.2 exh_312.htm EX-31.2 8673
7 EXHIBIT 32.1 exh_321.htm EX-32.1 3328
8 EXHIBIT 32.2 exh_322.htm EX-32.2 3271
15 GRAPHIC exh101a.jpg GRAPHIC 59708
16 GRAPHIC exh101b.jpg GRAPHIC 44272
17 GRAPHIC exh101c.jpg GRAPHIC 166388
18 GRAPHIC exh101d.jpg GRAPHIC 155390
  Complete submission text file 0001171843-15-005981.txt   5529791

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE FILE scmp-20150930.xml EX-101.INS 802842
10 XBRL SCHEMA FILE scmp-20150930.xsd EX-101.SCH 57554
11 XBRL CALCULATION FILE scmp-20150930_cal.xml EX-101.CAL 54310
12 XBRL DEFINITION FILE scmp-20150930_def.xml EX-101.DEF 455493
13 XBRL LABEL FILE scmp-20150930_lab.xml EX-101.LAB 340023
14 XBRL PRESENTATION FILE scmp-20150930_pre.xml EX-101.PRE 473444
Mailing Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814
Business Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814 3019613400
Sucampo Pharmaceuticals, Inc. (Filer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33609 | Film No.: 151196896
SIC: 2834 Pharmaceutical Preparations